| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c8cbbf2290b3f3a9988da29598baa2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9aa78ba483bde6eca6a7189f957cda5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7619c6cf796736aef4021dc689fe047f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a82de175bf00aae74b6f68747175f527 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-12 |
| filingDate |
2009-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9464bdff35defdd5b6ac666b80424b4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_939f3352da625db8f18211039a6b1af5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_759273f72f31c615a7826216c86388ba |
| publicationDate |
2010-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010039187-A2 |
| titleOfInvention |
Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| abstract |
The invention encompasses novel compounds and pharmaceutically acceptable salts thereof and compositions including therapeutically or prophylactically effective amounts of such compounds or pharmaceutically acceptable salts thereof. The invention also encompasses methods for treating or preventing diseases and disorders associated abnormal cell growth, for example, treating or preventing cancer or tumor growth, which methods include administering to a mammal in need thereof a composition comprising a therapeutically or prophylactically effective amount of a compound of the invention or a pharmaceutically acceptable salt thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9322831-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012225298-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014038682-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012122471-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9114158-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012122471-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015200779-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104769431-A |
| priorityDate |
2008-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |